A randomized open-label study to compare iron content in the blood of healthy subjects treated with Tasiron tablets containing ferric di-phosphate as compared to tablets containing ferrous ascorbate

Prashant Kulkarni; Sasikumar Menon

doi:10.18203/2349-3933.ijam20233567

Authors

Prashant Kulkarni S.P. Mandali’s Institute for Advanced Training and Research in Interdisciplinary Sciences, Mumbai, Maharashtra, India
Sasikumar Menon S.P. Mandali’s Institute for Advanced Training and Research in Interdisciplinary Sciences, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20233567

Keywords:

Anemia, Ferric di-phosphate, Ferrous ascorbate, IDA, Tasiron

Abstract

Iron deficiency anemia (IDA) frequently affects reproductive-age women, pregnant women, and children of growing age, particularly in developing countries like India. Traditional oral iron supplementation has various side effects, and therefore, liposomal technology has been introduced. This study compared serum iron levels in healthy adult female subjects treated with Tasiron tablets containing 30 mg (elemental iron) of micronized liposomal ferric di-phosphate, with those administered with tablets containing 100 mg (elemental iron) of ferrous ascorbate, over 15 days. The test group (n=7) received 30 mg of micronized liposomal ferric di-phosphate and the control group (n=7) received 100 mg of ferrous ascorbate. Serum levels of iron, hemoglobin, ferritin, and transferrin were measured from samples collected on days 1, 8, and 16 of the treatment periods. Higher iron content and hemoglobin levels were found at day 16 (p<0.05) and day 8 (p<0.05) as compared to day 1 in both groups. The test group received one-third the dose of iron that was administered to the control group. The group receiving 100 mg ferrous ascorbate had higher ferritin levels at day 8 (p<0.01) and day 16 (p<0.01) as compared to day 1. In the group receiving ferrous ascorbate, transferrin levels decreased on day 8 and 16. In contrast, there was an increase in transferrin levels in the group receiving liposomal iron. Oral liposomal iron effectively increases iron content and hemoglobin levels at one-third the concentration as compared to ferrous ascorbate. Further studies on larger numbers with a longer follow-up are required.

Metrics

Metrics Loading ...

References

Biniwale P, Pal B, Sundari T, Mandrupkar G, Datar N, Khurana A et al. Liposomal iron for iron deficiency anemia in women of reproductive age: review of current evidence. Open J Obstet Gynecol. 2018;11(8):993-1005.

Maladkar M, Sankar S, Yadav A. A novel approach for iron deficiency anaemia with liposomal iron: concept to clinic. J Biosci Med. 2020;8(9):27-41.

Hussain U, Zia K, Iqbal R, Saeed M, Ashraf N. Efficacy of a novel food supplement (Ferfer®) containing microencapsulated iron in liposomal form in female iron deficiency anemia. Cureus. 2019;11(5):e4603.

Malhotra J, Garg R, Malhotra N, Agrawal P. Oral liposomal iron: a treatment proposal for anemia. World J Anemia. 2017;1(4):1-6.

World Health Organization. Anaemia. Available at: https://www.who.int/news-room/fact-sheets/detail/anaemia. Accessed on 08 August, 2023.

Chavan S, Rana P, Tripathi R, Tekur U. Comparison of efficacy and safety of iron polymaltose complex and ferrous ascorbate with ferrous sulphate in pregnant women with iron-deficiency anaemia. Indian J Med Res. 2021;154(1):78-84.

Ministry of Health and Family Welfare. National Family Health Survey (NFHS 5). 2019-2020. Compendium of Fact Sheets: Key indicators India and 14 states/UTs (phase II). Available at: https://main.mohfw.gov.in/sites/default/files/NFHS-5_Phase-II_0.pdf. Accessed on 06 February, 2023.

Roganović J, Starinac K. Iron deficiency anemia in children. In: Khan J. Current topics in anemia. IntechOpen. 2018.

Chandra J, Dewan P, Kumar P, Mahajan A, Singh P, Dhingra B et al. Diagnosis, treatment and prevention of nutritional anemia in children: recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics. Indian Pediatr. 2022;59(10):782-801.

De Alvarenga Antunes CV, De Alvarenga Nascimento CR, De Rocha Ribeiro TC, De Alvarenga Antunes P, De Andrade Chebli L, Fava LMG et al. Treatment of iron deficiency anemia with liposomal iron in inflammatory bowel disease: efficacy and impact on quality of life. Int J Clin Pharm. 2020;42(3):895-902.

Nguyen M, Tadi P. Iron Supplementation. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2022.

Tolkien Z, Stecher L, Mander AP, Pereira DIA, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383.

Powers JM, Nagel M, Raphael JL, Mahoney DH, Buchanan GR, Thompson DI. Barriers to and facilitators of iron therapy in children with iron deficiency anemia. J Pediatr. 2020;219:202-8.

Baird-Gunning J, Bromley J. Correcting iron deficiency. Aust Prescr. 2016;39(6):193-9.